Canopy Growth Corp (WEED)

[john1311]

The Financial Times seems to deny cannabis a foothold in the business community.

I have complained because in yesterday’s FT article ( https://www.ft.com/content/f72c1f00-b254-11e6-a37c-f4a01f1b0fa1) the FT asked its readers if we wished to follow the topics mentioned in this article.

They mentioned 5 subjects to follow.

BUT NOT CANNABIS…. the main subject of the news article.

Why?

I have written to the FT editor asking:

Why as an investor does the FT deny me research + DD on a major global area of investment, namely medical cannabis?

Why does the FT deny its readers cannabis as a topic to follow?